MA29671B1 - 1,3-thiazole-5-carboxamides utiles comme agents chimiotherapeutiques anticancereux - Google Patents

1,3-thiazole-5-carboxamides utiles comme agents chimiotherapeutiques anticancereux

Info

Publication number
MA29671B1
MA29671B1 MA30269A MA30269A MA29671B1 MA 29671 B1 MA29671 B1 MA 29671B1 MA 30269 A MA30269 A MA 30269A MA 30269 A MA30269 A MA 30269A MA 29671 B1 MA29671 B1 MA 29671B1
Authority
MA
Morocco
Prior art keywords
thiazole
chemotherapeutic agents
anticancer chemotherapeutic
carboxamides useful
compounds
Prior art date
Application number
MA30269A
Other languages
English (en)
Inventor
Chih-Yuan Chuang
Philip Wickens
Zhenqiu Hong
Catherine Brennan
Julie A Dixon
Harold C E Kluender
Charles Kreiman
Ellalahewage Kumarasinghe
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of MA29671B1 publication Critical patent/MA29671B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

[1,3-Thiazole-5-carboxamides utiles comme agents chimiothérapeutiques contre le cancer] La présente invention concerne de nouveaux composés 1,3-thiazole-5-carboxamides, des compositions pharmaceutiques contenant de tels composés, et l'utilisation de ces composés ou compositions comme agents chimiothérapeutiques contre le cancer.
MA30269A 2005-03-04 2007-10-02 1,3-thiazole-5-carboxamides utiles comme agents chimiotherapeutiques anticancereux MA29671B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65898505P 2005-03-04 2005-03-04

Publications (1)

Publication Number Publication Date
MA29671B1 true MA29671B1 (fr) 2008-08-01

Family

ID=36676308

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30269A MA29671B1 (fr) 2005-03-04 2007-10-02 1,3-thiazole-5-carboxamides utiles comme agents chimiotherapeutiques anticancereux

Country Status (15)

Country Link
US (1) US20090023753A1 (fr)
EP (1) EP1858893A1 (fr)
JP (1) JP2008531688A (fr)
KR (1) KR20070118100A (fr)
CN (1) CN101133054A (fr)
AU (1) AU2006221037A1 (fr)
BR (1) BRPI0609147A2 (fr)
CA (1) CA2600039A1 (fr)
CR (1) CR9340A (fr)
EA (1) EA200701881A1 (fr)
IL (1) IL185518A0 (fr)
MA (1) MA29671B1 (fr)
MX (1) MX2007010099A (fr)
TN (1) TNSN07300A1 (fr)
WO (1) WO2006096338A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399774T3 (es) 2007-09-24 2013-04-03 Genentech, Inc. Compuestos de tiazolopirimidina inhibidores de PI3K y métodos de uso
KR101051078B1 (ko) 2008-12-05 2011-07-21 한국화학연구원 염증관련 질환치료제용 2,4-이중치환-5-아미노카르보닐-1,3-티아졸 유도체, 그의 제조방법 및 그를 유효성분으로 함유하는 ｓｐｃ 수용체 활성으로 유발되는 염증관련질환 치료제
WO2012036974A1 (fr) * 2010-09-14 2012-03-22 Schering Corporation Nouveaux dérivés de thiazol-carboximide en tant qu'inhibiteurs de pdk-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995162B2 (en) * 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
TWI299664B (en) * 2003-01-06 2008-08-11 Osi Pharm Inc (2-carboxamido)(3-amino)thiophene compounds
DE102004039876A1 (de) * 2004-06-23 2006-01-26 Lanxess Deutschland Gmbh Herstellung von fluorierten 1,3-Benzodioxanen

Also Published As

Publication number Publication date
EA200701881A1 (ru) 2008-02-28
WO2006096338A1 (fr) 2006-09-14
US20090023753A1 (en) 2009-01-22
CA2600039A1 (fr) 2006-09-14
TNSN07300A1 (en) 2008-12-31
CN101133054A (zh) 2008-02-27
IL185518A0 (en) 2008-01-06
AU2006221037A1 (en) 2006-09-14
JP2008531688A (ja) 2008-08-14
MX2007010099A (es) 2007-10-12
CR9340A (es) 2010-04-05
EP1858893A1 (fr) 2007-11-28
BRPI0609147A2 (pt) 2010-02-17
KR20070118100A (ko) 2007-12-13

Similar Documents

Publication Publication Date Title
MA29480B1 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
TNSN08196A1 (fr) Derives de pyrazine
MA30784B1 (fr) Derives phenyliques et utilisation de ceux-ci en tant qu'immunomodulateurs.
MA29652B1 (fr) 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
TNSN08139A1 (fr) Composes therapeutiques
WO2005004818A3 (fr) Composes heterocycliques et leur utilisation comme agents anticancereux
MA27427A1 (fr) Composes de benzimidazole-1-yl-thiophene utilises en cancerotherapie
ATE433447T1 (de) Pyrimiidinverbindungen
TNSN98238A1 (fr) Macrolides nouveaux
MA30988B1 (fr) Composes destines a inhiber la progression mitotique
MA29858B1 (fr) Derives de carbamoylbenzotriazole en tant qu'inhibiteurs de lipases et phospholipases
MA30042B1 (fr) Composes calcilytiques
MA30406B1 (fr) Nouveaux composes
MA30410B1 (fr) Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique.
MA29264B1 (fr) Pyroles et imidazoles substitues, compositions les contenant, procede de fabrication et utilisation
MA30916B1 (fr) Nouveaux derives de benzamide en tant qu'antagonistes de bradykinine
MA30331B1 (fr) ANTICORPS à EFGL 7 ET LEURS PROCEDES D'UTILISATION
MA31863B1 (fr) Dérivés de pyrazole comme inhibiteurs de 5-lo
MA27661A1 (fr) Indolone-oxazolidinones antibacteriennes, intermediaires pour leur preparation et compositions pharmaceutiques les contenant
MX2008002234A (es) Inhibidores de sulfonamida n-biciclico puenteados de gamma secretasa.
MA29248B1 (fr) Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation
MA29671B1 (fr) 1,3-thiazole-5-carboxamides utiles comme agents chimiotherapeutiques anticancereux
WO2006133006A3 (fr) 1-methyl-1h-pyrazole-4-carboxamides utiles comme agents chimiotherapeutiques anticancereux
MA31252B1 (fr) Macrolides a base d'erythromycine
TW200518742A (en) Entry inhibitors